Item 5.02          Departure of Directors or Certain Officers; Election of Directors;
                   Appointment of Certain Officers; Compensatory Arrangements of Certain
                   Officers.


On January 13, 2022, the Board of Directors ("Board") of McKesson Corporation
("Company") elected James H. Hinton and Kathleen Wilson-Thompson as directors of
the Corporation effective on January 13, 2022.
Mr. Hinton serves as an operating partner for the private equity firm Welsh,
Carson, Anderson & Stone. Prior to that, he held the role of chief executive
officer at Baylor Scott & White Health, the largest not-for-profit health system
in Texas, and held a variety of roles with Presbyterian Healthcare Services, New
Mexico's largest non-profit healthcare provider, including president and chief
executive officer.
Ms. Wilson-Thompson most-recently held the role of executive vice president and
global chief human resources officer at Walgreens Boots Alliance. Prior to that,
she held the role of senior vice president of global human resource at Kellogg
Company. She serves on the boards of directors of Tesla, Inc. and Wolverine
Worldwide.
The Company expects that the Board will appoint Mr. Hinton to the Compliance
Committee and Governance Committee and Ms. Wilson-Thompson to the Compensation
Committee and Governance Committee.
Mr. Hinton and Ms. Wilson-Thompson each will receive compensation in accordance
with the Company's standard compensatory arrangement for non-employee directors.
Each will receive an annual cash retainer of $80,000, which will be prorated
based on their election date. Each also will receive, effective February 7,
2022, restricted stock units ("RSUs") under the Company's 2013 Stock Plan in an
amount that represents the annual equity award value granted to non-management
directors after the Company's 2021 annual meeting of shareholders, prorated to
January 13, 2022. The number of RSUs to be granted to each will be determined by
dividing $94,191.78 by the closing price of the Company's common stock on
February 7, 2022.
In addition, effective January 13, 2022, Mr. Hinton and Ms. Wilson-Thompson each
will enter into the Company's standard Indemnification Agreement for directors,
which provides for indemnification to the fullest extent permitted by Delaware
law.
Item 7.01   Regulation FD Disclosure.

On January 18, 2022, the Company issued and posted on its website (https://www.mckesson.com/About-McKesson/Newsroom/Press-Releases/ and https://investor.mckesson.com/news/default.aspx) a news release announcing the elections of Mr. Hinton and Ms. Wilson-Thompson to the Board. A copy of that news release is attached hereto as Exhibit 99.1. The information contained in this item, including Exhibit 99.1, is furnished to the Commission, but shall not be deemed "filed" with the Commission for purposes of Section 18 of the Securities Exchange Act of 1934 ("Exchange Act"), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, except as expressly stated in any such filing. Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.
Exhibit No.                                              Description

       99.1               New    s release issued by McKesson Corporation on     January
                            1    8    , 20    2    2
        104             Cover Page Interactive Data File - the cover page iXBRL tags are embedded
                        within the Inline XBRL document

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses